American Association for Cancer Research Annual Meeting (AACR) | Conference

Michael Kim, MD, on Genetics and the Need for Novel Therapies in Pancreatic Cancer
April 20, 2021

Kim detailed the specifics of his research from the American Association for Cancer Research Annual Meeting 2021 focusing on novel therapies to target mutations and upstream or downstream pathways.

Thomas Marron, MD, PhD, on Research Design for the Neoantigen Peptide Vaccine, PGV-001
April 19, 2021

Marron detailed the research process for a phase 1 trial of PGV-001 presented virtually at the American Association for Cancer Research Annual Meeting 2021.

Complete Pathological Responses Seen for Resectable HCC Treated With Neoadjuvant Cemiplimab
April 17, 2021

Twenty percent of patients with resectable hepatocellular carcinoma experienced significant tumor necrosis when treated with neoadjuvant cemiplimab-rwlc, according to data from a phase 2a open label.